Baxter in advanced talks to acquire Hill-Rom for about $10 billion

  • Baxter International (NYSE:BAX) is in advanced discussions to buy Hill-Rom Holdings (NYSE:HRC) in a deal that could value the medical equipment maker at around $10B, The Wall Street Journal reported, citing people familiar with the matter.
  • The agreement to acquire Hill-Rom (HRC), valuing it at about $150 per share, could be reached as early as midweek, assuming the talks would continue, according to sources.
  • The news of the latest bid comes after Chicago-based Hill-Rom (HRC) rejected an earlier offer made by Baxter International (BAX) in July to acquire the company for $144 per share.

    Over the current book year the total revenu from the company based in Deerfield will be 12.61 billion USD (consensus estimates). This is slightly more than 2021's revenue of 11.67 billion USD.

    Historical revenues and results Baxter International plus estimates 2021

    financiële analyse

    The analysts expect for 2021 a net profit of 1.8 billion USD. Most of the analysts anticipate on a profit per share of 3.52 USD. The price/earnings-ratio therefore equals 23.03.

    Per share the analysts anticipate on a dividend of 1.05 USD per share. The dividend yield is then 1.3 percent. The average dividend yield of the pharmaceutical companies is a poor 1.37 percent.

    Baxter International 's market capitalization is based on the number of outstanding shares around 41.03 billion USD. -2

    At 17.57 the stock trades 1.94 percent higher at 81.06 USD.

    Historical stock prices Baxter International

    financial analysis baxterinternational

    ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
    news@valuespectrum.com

    Copyright analist.nl B.V.
    All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.

    • Sector news
    Analysts expect over 2024 revenue expansion Ontex
    Analysts expect revenue increase Intuitive Surgical
    Analysts: less sales Sonova
    Analysts count on revenue increase Ontex
    Intuitive Surgical's sales on record level according analysts' estimates
    KBC Securities Initiates Research Coverage of ONWARD® Medical with a Buy Rating and Target Price of EUR 10.00 Per Share
    Analysts: L'Oreal on steam for record sales
    National news
    NXP reaps benefits from FRAMOS collaboration
    Tesla net onder de 500.000 cars per year
    Analysts expect over 2024 revenue decrease Caterpillar
    Analysts expect sales decline Biogen
    Analysts anticipate for 2024 on revenue increase Cognizant
    Analysts expect over 2024 growing sales Colgate-Palmolive
    Analysts expect over 2024 revenue expansion Patterson-UTI Energy, relatively high dividend
    Press news
    Test News
    Annual General Meeting 2024 - Approval of all agenda items / Dividend / Election of the Supervisory Board
    Hitachi Rail Invests C$100m+ In Next Gen Urban Rail Signalling Technology
    Wellthy Announces Strategic Collaboration with Benefitfocus to Expand Benefits Solutions for Employee Caregivers and Their Families
    NGen Leads Assessment of Skills Requirements of the Canadian Manufacturing Workforce
    EllisDon and Impulse Partners Announce 2024 ConTech Accelerator Winners
    Transaction in Own Shares
    Logoanalist
    Returns European stocks
    Crypto currencies information
    About us Network Partners
    Fpgroup.nlinfo@analist.nlRSS feedContactIntellectual Property Photos Analist.nlLinksISIN
  • Glossary
    		• MorningstarPrudena.comAAII.comNASDAQvwd GroupEuronextBATS Chi-xBats
    ©2024 ValueSpectrum. All Rights Reserved
    Developed and maintained by  Velainn logo